参考文献/References:
[1]World Health Organization.Global status report on the public health response to dementia: executive summary[EB/OL].(2021-09-01)[2024-10-27].https://iris.who.int/handle/10665/344707.[2]吕旋瑞,徐静,林晓南,等.老年人血脂水平与阿尔茨海默病发病风险系统评价[J].中国公共卫生,2022,38(8):1066-1069.[3]Sinha K,Sun C,Kamari R,et al.Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia[J].Drug Discov Today,2020,25(4):793-799.[4]Yin Y,Tam HL,Quint J,et al.Epidemiology of Dementia in China in 2010-2020: A Systematic Review and Meta-Analysis[J].Healthcare (Basel),2024,12(3):334.[5]Jia L,Du Y,Chu L,et al.Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study[J].Lancet Public Health,2020,5(12):e661-e671.[6]李建军.《中国血脂管理指南(2023年)》核心要点解读[J].临床心血管病杂志,2023,39(7):491-494.[7]路佳秋,徐锦江.锦州地区体检老年人群轻度认知障碍患病现状及影响因素分析[J].慢性病学杂志,2024,25(11):1601-1606.[8]Liu H,Li J,Liu F,et al.Efficacy and safety of low levels of low-density lipoprotein cholesterol: trans-ancestry linear and non-linear Mendelian randomization analyses[J].Eur J Prev Cardiol,2023,30(12):1207-1215.[9]Kjeldsen EW,Thomassen JQ,Juul Rasmussen I,et al.Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies[J].Cardiovasc Res,2022,118(5):1330-1343.[10]European Alzheimer′s & Dementia Biobank Mendelian Randomization (EADB-MR) Collaboration,Luo J,Thomassen JQ,et al.Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease[J].JAMA Netw Open,2023,6(5):e2313734.[11]Iwagami M,Qizilbash N,Gregson J,et al.Blood cholesterol and risk of dementia in more than 1.8 million people over two decades: a retrospective cohort study[J].Lancet Healthy Longev,2021,2(8):e498-e506.[12]Larsson SC,Butterworth AS,Burgess S.Mendelian randomization for cardiovascular diseases: principles and applications[J].Eur Heart J,2023,44(47):4913-4924.[13]王浩桦,丁子琛,包绮晗,等.基于孟德尔随机化的血脂六项与冠心病因果关系研究[J].现代预防医学,2023,50(10):1736-1742,1753.[14]Slob EAW,Burgess S.A comparison of robust Mendelian randomization methods using summary data[J].Genet Epidemiol,2020,44(4):313-329.[15]Bowden J,Holmes MV.Meta-analysis and Mendelian randomization: A review[J].Res Synth Methods,2019,10(4):486-496.[16]Gronau QF,Wagenmakers EJ.Limitations of Bayesian Leave-One-Out Cross-Validation for Model Selection.Comput Brain Behav,2019,2(1):1-11.[17]Dutta S,Rahman S,Ahmad R,et al.An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia[J].Expert Rev Neurother,2021,21(12):1455-1472.[18]Turri M,Marchi C,Adorni MP,et al.Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders[J].Biochim Biophys Acta Mol Cell Biol Lipids,2022,1867(5):159123.[19]van der Kant R,Goldstein LSB,Ossenkoppele R.Amyloid-β-independent regulators of tau pathology in Alzheimer disease[J].Nat Rev Neurosci,2020,21(1):21-35.[20]Blanchard JW,Akay LA,Davila-Velderrain J,et al.APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes[J].Nature,2022,611(7937):769-779.[21]Lee H,Cho S,Kim MJ,et al.ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes[J].Cell Rep,2023,42(10):113183.[22]Essayan-Perez S,Südhof TC.Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer’s disease[J].Neuron,2023,111(20):3176-3194.e7.[23]Kjeldsen EW,Nordestgaard LT,Frikke-Schmidt R.HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review[J].Int J Mol Sci,2021,22(9):4547.[24]Zhang X,Geng T,Li N,et al.Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study[J].Nutrients,2022,15(1):69.[25]Hoglund K,Blennow K.Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer’s disease[J].CNS Drugs,2007,21(6):449-462.[26]Nordestgaard LT,Christoffersen M,Frikke-Schmidt R.Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease[J].Int J Mol Sci,2022,23(17):9777.[27]Sáiz-Vazquez O,Puente-Martínez A,Ubillos-Landa S,et al.Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis[J].Brain Sci,2020,10(6):386.
相似文献/References:
[1]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[2]刘 波,罗文静,张 翼,等.血清脂联素水平与轻度认知功能障碍的相关性研究[J].医学信息,2018,31(10):7.[doi:10.3969/j.issn.1006-1959.2018.10.003]
LIU Bo,LUO Wen-jing,ZHANG Yi,et al.Correlation between Serum Adiponectin Level and Mild Cognitive Impairment[J].Journal of Medical Information,2018,31(01):7.[doi:10.3969/j.issn.1006-1959.2018.10.003]
[3]朱 玉,戴 夫,彭 琼.胃肠息肉患者血脂水平影响因素及相关性分析[J].医学信息,2019,32(02):79.[doi:10.3969/j.issn.1006-1959.2019.02.023]
ZHU Yu,DAI Fu,PENG Qiong.Influential Factors and Correlation Analysis of Blood Lipid Levels in Patients with Gastrointestinal Polyps[J].Journal of Medical Information,2019,32(01):79.[doi:10.3969/j.issn.1006-1959.2019.02.023]
[4]张怀祥,段晓宇.脑梗死后认知障碍的病理学机制、相关危险因素及治疗[J].医学信息,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
ZHANG Huai-xiang,DUAN Xiao-yu.Pathological Mechanism,Related Risk Factors and Treatment of Cognitive Impairment after Cerebral Infarction[J].Journal of Medical Information,2018,31(01):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
[5]吴彦卿.妊娠期同型半胱氨酸和血脂水平对重度子痫前期的预测价值[J].医学信息,2018,31(16):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
WU Yan-qing.Predictive Value of Homocysteine and Blood Lipid Levels during Pregnancy in Severe Preeclampsia[J].Journal of Medical Information,2018,31(01):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
[6]林斯婕,吴 璇,覃 桓,等.卵巢癌合并2型糖尿病发生的危险因素分析[J].医学信息,2019,32(05):124.[doi:10.3969/j.issn.1006-1959.2019.05.039]
LIN Si-jie,WU Xuan,QIN Huan,et al.Analysis of Risk Factors for Ovarian Cancer Complicated with Type 2 Diabetes[J].Journal of Medical Information,2019,32(01):124.[doi:10.3969/j.issn.1006-1959.2019.05.039]
[7]沈有录,卢红涛,刘维军.阿托伐他汀和瑞舒伐他汀对高海拔地区PCI患者血脂、炎症因子和血管内皮功能的影响[J].医学信息,2019,32(06):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
SHEN You-lu,LU Hong-tao,LIU Wei-jun.Effects of Atorvastatin and Rosuvastatin on Blood Lipids,Inflammatory Factors and Vascular Endothelial Function in Patients with High Altitude PCI[J].Journal of Medical Information,2019,32(01):67.[doi:10.3969/j.issn.1006-1959.2019.06.022]
[8]杨 震,宗文仓,赵艳辉.血脂异常与老年冠心病患者冠脉病变程度的相关性研究[J].医学信息,2019,32(07):89.[doi:10.3969/j.issn.1006-1959.2019.07.026]
YANG Zhen,ZONG Wen-cang,ZHAO Yan-hui.Correlation Study between Dyslipidemia and Degree of Coronary Artery Disease in Elderly Patients with Coronary Heart Disease[J].Journal of Medical Information,2019,32(01):89.[doi:10.3969/j.issn.1006-1959.2019.07.026]
[9]承良凤.芜湖地区痛风急性发作诱因及临床生化特征初探[J].医学信息,2019,32(10):85.[doi:10.3969/j.issn.1006-1959.2019.10.028]
CHENG Liang-feng.Preliminary Study on the Causes and Clinical Biochemical Characteristics of Acute Gout in Wuhu Area[J].Journal of Medical Information,2019,32(01):85.[doi:10.3969/j.issn.1006-1959.2019.10.028]
[10]肖辛怡,严玉宁,魏文石.轻度行为损害的研究[J].医学信息,2019,32(13):49.[doi:10.3969/j.issn.1006-1959.2019.13.015]
XIAO Xin-yi,YAN Yu-ning,WEI Wen-shi.The Research of Mild Behavioral Damage[J].Journal of Medical Information,2019,32(01):49.[doi:10.3969/j.issn.1006-1959.2019.13.015]